Enter your terms above and click the 'Search' button.

Showing articles 0 to 11 of 11 Filter Applied: disability,neurological (Click to remove) Fat Embolism Syndrome in Sickle Cell Disease J Clin Med 9:1-12, Tsitsikas, D.A.,et al, 2020 Clinical Characteristics, Risk Factors, and Outcomes of POEMS Syndrome Neurol 95:e268-e279, Keddie, S.,et al, 2020 ICU-Acquired Weakness and Recovery from Critical Illness NEJM 370:1626-1635, Kress, J.P. & Hall, J.B., 2014 Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011 A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis NEJM 362:387-401, 456, Kappos, L.,et al, 2010 Gray Matter Involvement in Multiple Sclerosis Neurol 68:634-642, Pirko,I.,et al, 2007 MRI T2 Hypointensity of the Dentate Nucleus is Related to Ambulatory Impairment in Multiple Sclerosis J Neurol Sci 234:17-24, Tjoa,C.W.,et al, 2005 T2 Hypointensity in the Deep Gray Matter of Patients With Multiple Sclerosis Arch Neurol 59:62-68, Bakshi,R.,et al, 2002 Reduced Signal Intensity of T2 Weighted MR Imaging of Thalamus and Putamen in Multiple Sclerosis in Japan Rinsho Shinkeigaku 40:677-682, Nishii,T.,et al, 2000 Deteriorating Ischemic Stroke:Risk Factors and Prognosis Neurol 40:1865-1869, Davalos,A.,et al, 1990 Brain Damage by Neonatal Hypoglycaemia Editorial, Lancet 1:882-8831989., , 1989 Showing articles 0 to 11 of 11